Leveraging its Trypsin Activated Abuse Protection (TAAP) and Multi-Pill Abuse Resistance (MPAR™) platforms, the Company is in the process of developing a unique, tamper-proof treatment option for pain that minimizes the risk of both drug abuse and overdoses. The Company's new website has been completely redesigned by the team at Flipside Health, a London UK digital healthcare agency that unlocks the potential of digital and technology in the pharmaceutical, life sciences, consumer healthcare and public health sectors.Įnsysce Biosciences is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Understanding our TAAP TM and MPAR TM platforms is the foundation to understanding Ensysce and ultimately, our path towards commercialization and future successes." Our goal is to provide clear communications to anyone interested in our progress. As we put additional thought into our external image, it was imperative that chemistry was displayed as a prominent theme on our newly launched corporate website. Lynn Kirkpatrick, Chief Executive Officer of Ensysce, commented, "At Ensysce, our transformative chemistry is at the heart of our mission. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, today announced the launch of the new Ensysce website at The Company's updated website highlights the TAAP TM and MPAR TM technology platforms, the depth of the team, and our truly unique products for the treatment of severe pain.ĭr. SAN DIEGO, CA / ACCESSWIRE / Aug/ Ensysce Biosciences, Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |